Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis

U. Ko (Seoul, Republic of Korea)

Source: International Congress 2017 – ILDs: clinical aspects
Session: ILDs: clinical aspects
Session type: Thematic Poster
Number: 851
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Ko (Seoul, Republic of Korea). Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis. 851

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021



High-resolution computed tomography pattern reflects pathophysiologic difference in acute exacerbation of idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022



Prognostic value of cardiovascular parameters in computed tomography pulmonary angiography in patients with acute pulmonary embolism
Source: Eur Respir J, 52 (1) 1702611; 10.1183/13993003.02611-2017
Year: 2018



Lung biopsy in patients with suspected idiopathic pulmonary fibrosis and probable interstitial pneumonia on the CT scan.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

Assessment of operability by means of CTPA and perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


The role of lung ultrasonography in the assessment of idiopathic pulmonary fibrosis –correlation with HRCT finding
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Computed tomographic biomarkers in idiopathic pulmonary fibrosis
Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases
Year: 2019


Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020



Feasibility of registration between CT pulmonary angiography and lung perfusion spect in patients with severe chronic thrombembolic pulmonary hypertension
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009

Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019


Prevalence and clinical correlates of bronchoreversibility in severe emphysema
Source: Eur Respir J 2010; 35: 1048-1056
Year: 2010



Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Bronchodilator response assessed by computed tomography in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 141-146
Year: 2012



The utility of 18F-FDG PET/CT in chronic sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013